CompanyGraph
Shanghai Yizhong Pharmaceutical Co., Ltd.
688091 · SSE · China
yizhongpharma.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.23B, above the global median of $1.15B
- FinancialsHigh structural barrier to entry
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.30BCNY1.23B · vs all stocks (USD)
Trailing P/E
124.94xRevenue (TTM)
324.20MCNY48.21M · vs all stocks (USD)
Profit Margin
21.14%Beta
-0.4530xvs all stocks
52-Week Change
-44.58%vs all stocks
Market Capitalization
8.30BCNY1.23B · vs all stocks (USD)
Enterprise Value
7.73BCNY1.15B · vs all stocks (USD)
Trailing P/E
124.94xPrice to Sales (TTM)
27.08xPrice to Book (MRQ)
6.01xEnterprise to Revenue
23.83xEnterprise to EBITDA
140.88xGross Margin
85.26%Profit Margin
21.14%Operating Margin
15.56%Return on Assets (TTM)
1.77%Return on Equity (TTM)
4.77%Revenue (TTM)
324.20MCNY48.21M · vs all stocks (USD)
Revenue per Share (TTM)
1.61CNYUpdated Aug 21, 2026Quarterly Revenue Growth
11.40%Gross Profit (TTM)
271.08MCNY40.31M · vs all stocks (USD)
EBITDA (TTM)
75.15MCNY11.18M · vs all stocks (USD)
Net Income (TTM)
68.54MCNY10.19M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
28.10%Operating Cash Flow (TTM)
35.00MCNY5.20M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-168.27MCNY-25.02M · vs all stocks (USD)
Payout Ratio
0.00%Revenue
316.08MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
53.37MCNYFY2025 · Dec 31, 2025Gross Profit
262.71MCNYFY2025 · Dec 31, 2025Operating Income
49.96MCNY7.43M · vs all stocks (USD)
Pre-tax Income
61.15MCNYFY2025 · Dec 31, 2025Income Tax Expense
-3.41MCNYFY2025 · Dec 31, 2025Net Income
64.56MCNYFY2025 · Dec 31, 2025EBIT
61.22MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
77.92MCNYFY2025 · Dec 31, 2025Research & Development
86.37MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
66.47MCNYFY2025 · Dec 31, 2025Other Operating Expenses
1.34MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
13.81MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
67.15KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3200CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3200CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
201.74MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
201.74MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
64.56MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-50.27MCNYFY2025 · Dec 31, 2025Free Cash Flow
-180.36MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
43.89MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
64.56MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-10.83MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-81.94MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-22.06MCNYFY2025 · Dec 31, 2025Capital Expenditures
-130.09MCNYFY2025 · Dec 31, 2025Sale of Investments
6.43MCNYFY2025 · Dec 31, 2025Other Investing Activity
-450.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-573.65MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
25.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-73.75KCNYFY2025 · Dec 31, 2025Other Financing Charges
-32.41MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-7.48MCNYFY2025 · Dec 31, 2025Shares Outstanding
206.70MSharesUpdated Aug 21, 2026Float Shares
96.69MSharesUpdated Aug 21, 2026% Held by Insiders
51.50%vs all stocks
% Held by Institutions
6.10%vs all stocks
Total Cash (MRQ)
418.22MCNY62.19M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.04CNYUpdated Aug 21, 2026Total Debt (MRQ)
25.01MCNY3.72M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0173xCurrent Ratio (MRQ)
9.48xBook Value per Share (MRQ)
7.07CNYUpdated Aug 21, 2026Total Assets
1.53BCNY227.09M · vs all stocks (USD)
Total Current Assets
631.14MCNYFY2025 · Dec 31, 2025Total Liabilities
96.75MCNYFY2025 · Dec 31, 2025Total Non-current Assets
895.92MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
27.90MCNYFY2025 · Dec 31, 2025Total Current Liabilities
68.85MCNYFY2025 · Dec 31, 2025Cash
43.89MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
43.89MCNYFY2025 · Dec 31, 2025Other Short-term Investments
370.73MCNYFY2025 · Dec 31, 2025Accounts Receivable
102.65MCNYFY2025 · Dec 31, 2025Inventory
62.50MCNYFY2025 · Dec 31, 2025Accounts Payable
52.07MCNYFY2025 · Dec 31, 2025Short-term Debt
12.50KCNYFY2025 · Dec 31, 2025Other Current Liabilities
544.26KCNYFY2025 · Dec 31, 2025Long-term Debt
25.00MCNYFY2025 · Dec 31, 2025Common Stock (Book)
206.70MCNYFY2025 · Dec 31, 2025Retained Earnings
221.72MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.43BCNY212.70M · vs all stocks (USD)
Treasury Stock
72.24MCNYFY2025 · Dec 31, 202552-Week Low
35.28CNYUpdated Aug 21, 202652-Week High
75.49CNYUpdated Aug 21, 202652-Week Change
-44.58%vs all stocks
Beta
-0.4530xvs all stocks
50-Day MA
40.64CNYUpdated Aug 21, 2026200-Day MA
49.62CNYUpdated Aug 21, 2026Avg 10-Day Volume
4.44MSharesUpdated Aug 21, 2026Avg 30-Day Volume
4.23MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.3400CNYUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 1.95
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.23B, above the global median of $1.15BNotable
Market cap (USD): 1,233,551,988.926Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Sequent Scientific Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Viyash Scientific Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Xianju Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Kissei Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Guangdong Taienkang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Alpha Tau Medical Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hubei Hongyuan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Carsgen Therapeutics Holdings Limited
Tier 1ProductionApproval-Gated PipelineRule
MannKind Corporation
Tier 1ProductionApproval-Gated PipelineRule
Artivion Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationMinimal Tax and Interest Drag
Mahindra Lifespace Developers Ltd.
1 interpretationMinimal Tax and Interest Drag
Prakash Industries Ltd.
1 interpretationMinimal Tax and Interest Drag